| Trial ID: | L1583 |
| Source ID: | NCT01214395
|
| Associated Drug: |
5% Tea Tree Oil Nasal Ointment
|
| Title: |
Nasal Tea Tree Oil for the Prevention of Infections in PD Patients
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT01214395/results
|
| Conditions: |
End Stage Renal Failure on Dialysis
|
| Interventions: |
DRUG: 5% tea tree oil nasal ointment
|
| Outcome Measures: |
Primary: Primary Endpoint Will be the Number of Tea Tree Oil Patients That Did Not Have a Catheter-related Infection Within 6 Months After Entry Into the Trial., Catheter-related infections will be defined according to standard guidelines Cases with "definite" and "probable" infections will be classified as infections., 6 months | Secondary: The Number of Patients That Did Not Have a Staphylococcus Aureus Infection, 6 months
|
| Sponsor/Collaborators: |
Sponsor: PathWest Laboratory Medicine WA
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
5
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: PREVENTION
|
| Start Date: |
2010-06
|
| Completion Date: |
2011-12
|
| Results First Posted: |
2012-08-03
|
| Last Update Posted: |
2012-08-03
|
| Locations: |
Sir Charles Gairdner Hospital, Perth, Western Australia, 6009, Australia
|
| URL: |
https://clinicaltrials.gov/show/NCT01214395
|
